SEC Form 4 · accession 0001246360-16-006440
NxStage Medical, Inc. · NXTM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Daniel A Giannini
Director
Period of report
Aug 4, 2016
Accepted (ET)
Aug 8, 2016 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001333170
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 4, 2016 | M | 15,272 | $14.99 | A | 79,245 | D | |
| Common Stock | Aug 4, 2016 | F | 9,603 | $23.84 | D | 69,642 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $14.99 | Aug 4, 2016 | M | 15,272 | D | May 24, 2012 | May 23, 2017 | Common Stock | 15,272 | 0 | D |